Table 4.
Diagnosis | Clinical clone | Concordant screening sites | Discordant screening sites | ||||||
---|---|---|---|---|---|---|---|---|---|
EA | P | Rc | U | EA | P | Rc | U | ||
VAP | A | + | + | + | + | ||||
K2 | + | + | |||||||
E1 | + | + | |||||||
I1 | + | + | + | ||||||
R | + | + | |||||||
S1 | + | + | + | ||||||
S2 | + | + | + | ||||||
U | + | + | + | ||||||
Screen site utility for VAP (%) | 7/8 (87) | 6/8 (75) | 4/8 (50) | NA | NA | 1/8 (12) | 4/8 (50) | NA | |
SSI | B1 | + | + | ||||||
C2 | + | ||||||||
O | + | + | |||||||
P | + | + | + | + | |||||
Screen site utility for SSI (%) | 2/4 (50) | 2/4 (50) | 2/4 (50) | 1/4 (25) | NA | NA | 2/4 (50) | NA | |
BSI | G | + | + | + | |||||
IAI | D1 | + | |||||||
Screen site utility for all infections (%) | 10/14 (71) | 9/14 (64) | 8/14 (57) | 1/14 (7) | NA | 1/14 (7) | 6/14 (43) | NA |
VAP ventilator associated pneumonia, SSI surgical site infection, BSI blood stream infection, IAI intraabdominal infection, EA endotracheal aspirate, P pharynx, Rc rectum, U urine